Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor.

In UM-X7.1 hamster model of human dilated cardiomyopathy, heart failure progressively develops and causes 50% mortality by 30 weeks of age. Through ultrastructural analysis, we found that many cardiomyocytes of this model contain typical autophagic vacuoles including degraded mitochondria, glycogen granules, and myelin-like figures. In addition, ubiquitin, cathepsin D, and Rab7 were overexpressed as determined by immunoassays. Importantly, most cardiomyocytes with leaky plasma membranes were positive for cathepsin D, suggesting a direct link between autophagic degeneration and cell death. Meanwhile, cardiomyocyte apoptosis appeared insignificant. Granulocyte colony-stimulating factor (10 microg/kg/day), injected 5 days/week from 15 to 30 weeks of age, improved survival among 30-week-old hamsters (100% versus 53% in the untreated hamsters, P < 0.0001); ventricular function and remodeling, increased cardiomyocyte size, and reduced myocardial fibrosis followed by a dramatic reduction in the autophagic findings were also seen. Granulocyte colony-stimulating factor also down-regulated tumor necrosis factor-alpha and increased activities of Akt signal transducer and activator of transcription-3, and matrix metalloproteinases. However, there was no clear evidence of transdifferentiation from bone marrow cells into cardiomyocytes. In conclusion, autophagic death is important for cardiomyocyte loss in the cardiomyopathic hamster, and the beneficial effect of granulocyte colony-stimulating factor acts mainly via an anti-autophagic mechanism rather than anti-apo-ptosis or regeneration.

[1]  T. Aoyama,et al.  Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. , 1999, Circulation.

[2]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[3]  D. Lloyd‐Jones,et al.  The risk of congestive heart failure: sobering lessons from the framingham heart study , 2001, Current cardiology reports.

[4]  M. Martone,et al.  Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster , 2002, Basic Research in Cardiology.

[5]  M. Colombo,et al.  Rab7 is required for the normal progression of the autophagic pathway in mammalian cells , 2004, Journal of Cell Science.

[6]  R. Visse,et al.  Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .

[7]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[8]  Y. Taniyama,et al.  Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. , 2000, Circulation.

[9]  B. Greenberg,et al.  Molecular Medicine Tumor Necrosis Factor-�–Induced AT 1 Receptor Upregulation Enhances Angiotensin II–Mediated Cardiac Fibroblast Responses That Favor Fibrosis , 2022 .

[10]  J. Schaper,et al.  Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. , 2000, Journal of molecular and cellular cardiology.

[11]  I. Komuro,et al.  Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  M. Arai,et al.  Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment , 2004, Circulation.

[13]  J. Baker,et al.  New hereditary disease of Syrian hamsters. Primary, generalized polymyopathy and cardiac necrosis. , 1962, Archives of internal medicine.

[14]  G. Jasmin,et al.  Hereditary polymyopathy and cardiomyopathy in the syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM‐X7.1 line , 1982, Muscle & nerve.

[15]  J. Schaper,et al.  Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.

[16]  P. Kang,et al.  Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Spieckermann,et al.  Culturing of calcium stable adult cardiac myocytes. , 1982, Journal of molecular and cellular cardiology.

[18]  Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy , 2000 .

[19]  Y. Kitaura,et al.  Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. , 2001, Japanese circulation journal.

[20]  S. Dimauro,et al.  Lysosomal glycogen storage disease with normal acid maltase , 1981, Neurology.

[21]  K. Campbell,et al.  Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.

[22]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[23]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Ikehara,et al.  Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. , 2001, Blood.

[25]  B. Avalos,et al.  Molecular analysis of the granulocyte colony-stimulating factor receptor. , 1996, Blood.

[26]  A. Salama,et al.  Matrix metalloproteinase‐9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G–CSF , 2002, Transfusion.

[27]  Hiroshi Sato,et al.  Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: Amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Ristic,et al.  Dilated Cardiomyopathies as a Cause of Congestive Heart Failure , 2002, Herz.

[29]  M. Matsui,et al.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.

[30]  J. Ross,et al.  Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[31]  P. Libby,et al.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. , 2000, The Journal of clinical investigation.

[32]  F. Dong,et al.  Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. , 2000, Blood.

[33]  M. Wheeler,et al.  Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. , 2004, The Journal of clinical investigation.

[34]  Afshin Samali,et al.  Losing heart: the role of apoptosis in heart disease—a novel therapeutic target? , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  T. Aoyama,et al.  Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: beating and rate are associated with the apoptotic process. , 2001, The American journal of pathology.

[36]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[37]  S. Dimauro,et al.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) , 2000, Nature.

[38]  S. Emr,et al.  Autophagy as a regulated pathway of cellular degradation. , 2000, Science.

[39]  J. Schaper,et al.  Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.

[40]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[41]  W. Krüger,et al.  A randomized comparison of once versus twice daily recombinant human granulocyte colony‐stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation , 2000, British journal of haematology.

[42]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[43]  J. Towbin,et al.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. , 2000, The Journal of clinical investigation.

[44]  M J Davies,et al.  Apoptotic versus autophagic cell death in heart failure. , 2001, Cardiovascular research.

[45]  M. Okabe,et al.  Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Lüllmann-Rauch,et al.  Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice , 2000, Nature.

[47]  M. G. Honig,et al.  Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures , 1986, The Journal of cell biology.

[48]  K. Campbell,et al.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. , 2001, The Journal of clinical investigation.

[49]  J. Dees,et al.  Cardiac Lysosomal Derangements in Mouse Heart after Long‐Term Exposure to Nonmetabolizable Sugars , 1977, Circulation research.

[50]  I. Komuro,et al.  G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes , 2005, Nature Medicine.

[51]  C. Croce,et al.  Mechanism of Enhanced Cardiac Function in Mice with Hypertrophy Induced by Overexpressed Akt* , 2003, Journal of Biological Chemistry.